Brooklyn Investment Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$712K Buy
32,336
+20,253
+168% +$353K 0.02% 768
2025
Q4
$145K Buy
+12,083
New +$155K 0.01% 1428
2025
Q3
Sell
-2,776
Closed -$31.8K 999
2025
Q2
$31.8K Buy
2,776
+1,222
+79% +$13.8K ﹤0.01% 1602
2025
Q1
$21K Sell
1,554
-382
-20% -$6.34K ﹤0.01% 1149
2024
Q4
$32.7K Buy
1,936
+96
+5% +$1.87K 0.01% 636
2024
Q3
$37.4K Buy
+1,840
New +$37.6K 0.01% 545

Other funds holding CC

Brooklyn Investment Group's CC Position: Q1 2026 in Review

Brooklyn Investment Group increased its Chemours (CC) stake by 168% in Q1 2026, buying an estimated $353K and bringing the position to 32,336 shares worth $712K. The position accounts for 0.02% of the portfolio, ranked #768.

Brooklyn Investment Group first reported a position in CC in Q3 2024 and has held it in 6 quarters since. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Brooklyn Investment Group held 32,336 shares of Chemours worth $712K as of Q1 2026.
  • Brooklyn Investment Group bought 20,253 Chemours shares in Q1 2026, an estimated $353K.
  • Chemours made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #768 holding.
  • Brooklyn Investment Group first reported a position in Chemours in Q3 2024 and has held it in 6 quarters since.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.